Introductory Chapter: Multidisciplinary Colorectal Cancer - First Steps to Encompass Various Strategies for Preventing and Treating Colorectal Cancer

Keun-Yeong Jeong
{"title":"Introductory Chapter: Multidisciplinary Colorectal Cancer - First Steps to Encompass Various Strategies for Preventing and Treating Colorectal Cancer","authors":"Keun-Yeong Jeong","doi":"10.5772/intechopen.89977","DOIUrl":null,"url":null,"abstract":"Over the past decades, significant progress has been made in clinical and preclinical sciences. It has been lucky to see the integration of multiple discovery disciplines in science and medicine to push the limits of diagnosis and treatment of disorders that can affect many diseases. However, cancer is an exceptional disease that is relatively intractable and despite the multiple discovery disciplines scholarly. Colorectal cancer (CRC) is the third most common cause of cancer-associated mortality worldwide. According to the data from the National Center for Health Statistics, about 135,000 people are estimated to undergo chemotherapy with CRC in the USA each year, and approximately 50,000 people succumb to the disease annually [1]. Additionally, estimation of the Global Cancer Control project indicated that nearly 2 million people worldwide were diagnosed every year [2]. Wellknown option targeting CRC treatment is currently suggested surgical resection preferentially, and if the tumor progression is in an advanced stage, it does require combination with chemotherapy and/or radiation therapy. There is no doubt that surgery, chemotherapy, and radiation therapy are the best choices for treating CRC, even therapeutic efficiency is improving. However, it is still insufficient to reach a convincing level except for the case of early detection; therefore the craving for better potential therapies is still ongoing.","PeriodicalId":334373,"journal":{"name":"Multidisciplinary Approach for Colorectal Cancer","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multidisciplinary Approach for Colorectal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/intechopen.89977","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Over the past decades, significant progress has been made in clinical and preclinical sciences. It has been lucky to see the integration of multiple discovery disciplines in science and medicine to push the limits of diagnosis and treatment of disorders that can affect many diseases. However, cancer is an exceptional disease that is relatively intractable and despite the multiple discovery disciplines scholarly. Colorectal cancer (CRC) is the third most common cause of cancer-associated mortality worldwide. According to the data from the National Center for Health Statistics, about 135,000 people are estimated to undergo chemotherapy with CRC in the USA each year, and approximately 50,000 people succumb to the disease annually [1]. Additionally, estimation of the Global Cancer Control project indicated that nearly 2 million people worldwide were diagnosed every year [2]. Wellknown option targeting CRC treatment is currently suggested surgical resection preferentially, and if the tumor progression is in an advanced stage, it does require combination with chemotherapy and/or radiation therapy. There is no doubt that surgery, chemotherapy, and radiation therapy are the best choices for treating CRC, even therapeutic efficiency is improving. However, it is still insufficient to reach a convincing level except for the case of early detection; therefore the craving for better potential therapies is still ongoing.
导论章:多学科结直肠癌-第一步包括预防和治疗结直肠癌的各种策略
在过去的几十年里,临床和临床前科学取得了重大进展。幸运的是,我们看到了科学和医学中多个发现学科的整合,推动了对可能影响许多疾病的疾病的诊断和治疗的极限。然而,癌症是一种特殊的疾病,相对难以治疗,尽管有多个学科的学术发现。结直肠癌(CRC)是全球癌症相关死亡的第三大常见原因。根据美国国家卫生统计中心的数据,美国每年约有13.5万人因结直肠癌接受化疗,每年约有5万人死于该疾病[1]。此外,据全球癌症控制项目估计,全球每年有近200万人被诊断出来[2]。目前,针对结直肠癌的治疗方案是首选手术切除,如果肿瘤进展到晚期,则需要联合化疗和/或放疗。毫无疑问,手术、化疗和放疗是治疗结直肠癌的最佳选择,甚至治疗效率也在提高。但是,除了早期发现的情况外,仍不足以达到令人信服的水平;因此,对更好的潜在疗法的渴望仍在继续。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信